BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23709434)

  • 1. Stepwise treatment using corticosteroids alone and in combination with cyclosporine in korean patients with idiopathic membranous nephropathy.
    Shin DH; Lee MJ; Oh HJ; Koo HM; Doh FM; Kim HR; Han JH; Park JT; Han SH; Choi KH; Yoo TH; Kang SW
    Yonsei Med J; 2013 Jul; 54(4):973-82. PubMed ID: 23709434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.
    Choi JY; Kim DK; Kim YW; Yoo TH; Lee JP; Chung HC; Cho KH; An WS; Lee DH; Jung HY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2018 Feb; 33(9):e74. PubMed ID: 29441742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
    Kim Y; Yoon HE; Chung BH; Choi BS; Park CW; Yang CW; Kim YS; Hong YA; Kim SY; Chang YK; Hwang HS
    Korean J Intern Med; 2019 Sep; 34(5):1091-1099. PubMed ID: 31408925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    Fervenza FC; Appel GB; Barbour SJ; Rovin BH; Lafayette RA; Aslam N; Jefferson JA; Gipson PE; Rizk DV; Sedor JR; Simon JF; McCarthy ET; Brenchley P; Sethi S; Avila-Casado C; Beanlands H; Lieske JC; Philibert D; Li T; Thomas LF; Green DF; Juncos LA; Beara-Lasic L; Blumenthal SS; Sussman AN; Erickson SB; Hladunewich M; Canetta PA; Hebert LA; Leung N; Radhakrishnan J; Reich HN; Parikh SV; Gipson DS; Lee DK; da Costa BR; Jüni P; Cattran DC;
    N Engl J Med; 2019 Jul; 381(1):36-46. PubMed ID: 31269364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
    Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
    Cattran DC; Appel GB; Hebert LA; Hunsicker LG; Pohl MA; Hoy WE; Maxwell DR; Kunis CL;
    Kidney Int; 2001 Apr; 59(4):1484-90. PubMed ID: 11260412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out of Africa: Complete and partial remissions as a combined outcome in patients with idiopathic membranous glomerulonephritis in Cape Town.
    Ameh OI; Swanepoel CR; Aderibigbe A; Kengne AP; Okpechi IG
    Nephrology (Carlton); 2016 Dec; 21(12):1010-1016. PubMed ID: 26706191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of diabetes with failure to achieve complete remission of idiopathic membranous nephropathy.
    Xie H; Li C; Wen Y; Ye W; Cai J; Li H; Li X; Li X
    Int Urol Nephrol; 2020 Feb; 52(2):337-342. PubMed ID: 31820359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of membranous nephropathy.
    Ponticelli C; Passerini P
    Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
    Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
    Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yokoyama H; Yamamoto R; Imai E; Maruyama S; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Fukami K; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Furuichi K; Fujimoto K; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
    Clin Exp Nephrol; 2020 Oct; 24(10):893-909. PubMed ID: 32562107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
    Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy.
    Li MX; Yu YW; Zhang ZY; Zhao HD; Xiao FL
    Genet Mol Res; 2015 Mar; 14(1):2665-73. PubMed ID: 25867415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.